MARKET

JNJ

JNJ

Johnson & Johnson
NYSE
160.79
-1.05
-0.65%
Pre Market: 160.65 -0.14 -0.09% 06:07 02/27 EST
OPEN
161.80
PREV CLOSE
161.84
HIGH
162.01
LOW
160.57
VOLUME
12
TURNOVER
0
52 WEEK HIGH
175.97
52 WEEK LOW
142.71
MARKET CAP
387.31B
P/E (TTM)
11.71
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at JNJ last week (0219-0223)?
Weekly Report · 1d ago
Tracking Ray Dalio's Bridgewater Associates 13F Portfolio - Q4 2023 Update
Bridgewater Associates' 13F portfolio value increased from $16.55B to $17.86B in Q4 2023. The top three individual stock positions are Procter & Gamble, Coca-Cola, and Costco. Stake increases include iShares Core S&P 500 ETF, Johnson & Johnson, Alphabet, and Visa.
Seeking Alpha · 1d ago
Needham sees orthopedics market slowing; favors Enovis, Paragon 28
Healthcare Needham sees orthopedics market slowing; favors Enovis, Paragon 28. Needham says it expects growth in the orthopedic device market to slow to 4% to 5% for 2024 and beyond. The investment bank says it sees growth in 2023 at the highest rate in over ten years.
Seeking Alpha · 1d ago
A $100,000 Dividend Snowball From A 5.5%-Yielding All-Weather Portfolio
Home Dividends Analysis Dividend Strategy A $100,000 Dividending Snowball From A 5.5%-Yielding All-Weather Portfolio. Charlie Munger and Ray Dalio provide wisdom on how to invest for long-term financial freedom. We combine their wisdom with the power of dividend growth investing to build a high-yielding all-weather dividend growth snowball.
Seeking Alpha · 1d ago
BMO upgrades Genmab to outperform, cites diversification potential
Healthcare BMO upgrades Genmab to outperform, cites diversification potential for Darzalex. BMO raised its price target for the stock to $48 from $46. The investment bank cites the company's ability to diversify away from reliance on Johnson & Johnson.
Seeking Alpha · 3d ago
Legend Biotech stock rises after EU backs label expansion for multiple myeloma therapy
Legend Biotech stock rises after EU backs label expansion for multiple myeloma therapy. Carvykti, a BCMA-directed autologous CAR-T cell therapy, is marketed by Johnson & Johnson-owned Janssen Biotech in partnership with Legend Biotech.
Seeking Alpha · 3d ago
Evaluating Johnson & Johnson Against Peers In Pharmaceuticals Industry
Johnson & Johnson is the world's largest and most diverse healthcare firm. The company is being divested in 2023 under the new name of Kenvue. Johnson & Johnson has been compared to its major competitors in the Pharmaceuticals industry. The firm shows potential for growth at a reasonable price.
Benzinga · 3d ago
Johnson & Johnson wins EU backing to expand labeling for CAR-T therapy
Johnson & Johnson wins EU backing to expand labeling for CAR-T therapy for multiple myeloma. Carvykti is marketed by J&J in partnership with Legend Biotech. The European Medicines Agency endorsed its CAR-t cell therapy to expand its label for the disease.
Seeking Alpha · 3d ago
More
About JNJ
Johnson & Johnson is a diversified healthcare products company. The Company is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through two segments: Pharmaceutical and MedTech. Its primary focus is products related to human health and well-being. The Pharmaceutical segment is focused on six therapeutic areas: Immunology, Infectious Diseases, Neuroscience, Oncology, Cardiovascular and Metabolism and Pulmonary Hypertension. The MedTech segment includes a range of products used in the interventional solutions, orthopedics, surgery, and vision fields. Its geographic area includes the United States, Europe, Western Hemisphere (excluding the United States), and Africa, Asia and Pacific.

Webull offers Johnson & Johnson stock information, including NYSE: JNJ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, JNJ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading JNJ stock methods without spending real money on the virtual paper trading platform.